The nanosystem abrogated IL expression, shut down after CCL22 secretion, and restricted Treg cell accumulation within the tumor site to induce sufficient antitumor immune responses (i.e., activated sufficient CD8+ T cells, IFN-γ, and TNF-α) with X- and NIR-induced therapeutic effects. Here, CD8A is linked to neoplasm.